Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

The 5th Annual Symposium of the Centre for Genomic Regulation (CRG) will focus on Systems Biology

14.12.2006
Next 15th and 16th December world renowned scientists and experts in the field of Systems Biology from Europe and United States will join in Barcelona at the 5th Annual Symposium of the Centre for Genomic Regulation (CRG), organized by Luis Serrano, coordinator of the research programme on Systems Biology at the CRG, and director of the EMBL/CRG Systems Biology Research Unit.

It is expected the participation of the following guest speakers: Peer Bork, from EMBL in Heidelberg (Germany); Timothy Gardner, from the Boston University (USA); Mads Kaern, from the University of Ottawa (Canada); Nadav Kashtan, from the Weizmann Institute of Science in Rehovot (Israel); Patrick Lemaire, from the Developmental Biology Institute of Marseilles-Luminy (France); Martin Lercher, from the University of Bath (United Kingdom); Alfonso Martínez-Arias, from the University of Cambridge (United Kingdom); Uwe Sauer, from the Institute for Molecular Systems Biology-ETH in Zurich (Switzerland); Ricard V. Solé, from the Universitat Pompeu Fabra in Barcelona (Spain); Marc Vidal, from the Dana-Farber Institute in Boston (USA); Ron Weiss, from Princeton University (USA); Mark Isalan and James Sharpe, both from the Centre for Genomic Regulation in Barcelona (Spain).

Systems Biology is an emerging discipline that aims at a quantitative understanding of biological systems to an extent that one is able to predict its response to external (drugs) or internal (mutations) disturbances and, in the future, even to modify them rationally (Synthetic Biology). The most obvious applications of Systems Biology are in the field of medicine. At the moment, the way medicine works is by using very similar drugs and treatments for everyone. We are all aware of the multibillion losses that pharmaceutical companies have suffered in the last years due to the commercialization of drugs that, although beneficial for a large part of the population are harmful for certain groups of people. Treatment of diseases today remains still to a large extent the same as when aspirin was discovered. Essentially either serendipitously or through the identification of putative targets in basic research a massive screening is done helped or lead by design software, and candidate drugs are then tested on different systems to assess their toxicity and potency. Drugs that pass this stage are then validated by very costly medical trails involving thousands of patients.

All this procedure is very costly and inefficient and it is based on the assumption that human diseases can be cured with a single drug. However, it is quite obvious that the majority of us will not die because of a single faulty gene, but because of the combination of many small alterations on different genes (multifactorial diseases) combined with our life style. Multifactorial diseases are hard to treat since they involve more than one gene product in an organism, often working in different cellular pathways. Thus we need first to be able to understand in a global and quantitative way how a complex biological system as the human being operates, to be able to tackle in a rational way the treatment of complex diseases. This is precisely one of the aims of Systems Biology.

Gloria Lligadas | alfa
Further information:
http://www.crg.es
http://pasteur.crg.es/portal/page/portal/Internet/04_EVENTS/HIDE-EVENTS/171E603F978A20E3E04012AC0E016846

Further reports about: 5th CRG United biological system

More articles from Life Sciences:

nachricht Climate Impact Research in Hannover: Small Plants against Large Waves
17.08.2018 | Leibniz Universität Hannover

nachricht First transcription atlas of all wheat genes expands prospects for research and cultivation
17.08.2018 | Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>